Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study
Open Access
- 26 June 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 49 (3), 835-841
- https://doi.org/10.1093/ejcts/ezv239
Abstract
Thymic carcinoma is a rare thymic malignancy. The purpose of this study was to evaluate the prognostic impact of clinicopathological variables and perioperative therapy for surgically treated thymic carcinoma using a nationwide database. Of 2835 patients with surgically treated thymic epithelial tumours collected from 32 Japanese institutions, a total of 306 patients with thymic carcinomas, excluding neuroendocrine tumours, were enrolled in this retrospective study. Multivariable Cox regression analyses were performed for overall (OS) and recurrence-free survival (RFS) after R0 resection. Of 306 patients, 228 (75%) patients presented with Masaoka stage III–IV. Squamous cell carcinoma was the most common histological type ( n = 216, 71%). R0 resection was performed in 181 (61%) patients, R1 in 46 (16%), R2 sub-total (≥80% tumour resection) in 43 (14%) and R2 non-resection in 27 (9%). The 5-year OS rate was 61%. Prognostic factors for OS were Masaoka stage and resection status. R0 resection was associated with most improved OS; however, both R1 and R2 sub-total resection resulted in superior OS compared with R2 non-resection [hazard ratio (95% confidence interval) for R0, R1 and R2 sub-total, 0.27 (0.15–0.48), 0.40 (0.22–0.74) and 0.38 (0.20–0.72), respectively]. Histological type and perioperative therapy did not affect OS, whereas tumour size and postoperative radiotherapy were associated with improved RFS after R0 resection. R0 resection is essential for prolonged OS for surgically treated thymic carcinoma, but maximal debulking surgery might be beneficial and worth evaluating for advanced disease deemed difficult for R0 resection. The benefit of postoperative radiotherapy after R0 resection should also be evaluated prospectively.Keywords
This publication has 24 references indexed in Scilit:
- Thymic Carcinoma: A Cohort Study of Patients from the European Society of Thoracic Surgeons DatabaseJournal of Thoracic Oncology, 2014
- Thymic Carcinoma: Outcomes After Surgical ResectionThe Annals of Thoracic Surgery, 2012
- Thymic Carcinoma: Is it a Separate Entity? From Molecular to Clinical EvidenceThoracic Surgery Clinics, 2011
- Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution☆European Journal of Cardio-Thoracic Surgery, 2009
- Comparison of patterns of relapse in thymic carcinoma and thymomaThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Thymic Carcinoma: 30 Cases at a Single InstitutionJournal of Thoracic Oncology, 2008
- Thymic carcinoma: a clinicopathological and immunohistological study of 19 casesHistopathology, 2004
- Thymic carcinoma: involvement of great vessels indicates poor prognosisThe Annals of Thoracic Surgery, 2003
- Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from JapanThe Annals of Thoracic Surgery, 2003
- Thymic carcinoma. A clinicopathologic study of 60 casesCancer, 1991